O.C.G.A.
O.C.G.A.

O.C.G.A. § 33-53-2 (2019)

Conditions of coverage

✓ O.C.G.A.: 2019 edition (Public.Resource.Org Release 73)
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases: SyfertCases citing this section GA-LEGlegis.ga.gov (official) JustiaJustia CornellLII Search CasesGoogle Scholar

An insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:

(1) The drug is recognized for treatment of the indication in at least one standard reference compendium;

(2) The drug is recommended for that particular type of cancer and found to be safe and effective in formal clinical studies, the results of which have been published in a peer reviewed professional medical journal published in either the United States or Great Britain.

History

Code 1981, § 33-53-2, enacted by Ga. L. 1993, p. 539, § 1.

Annotations

Code Commission notes. - Pursuant

to Code Section 28-9-5, in 1993, ‘‘peer reviewed’’ was substituted for ‘‘peer-reviewed’’ in paragraph (2).